Company / Inventory
Mirum Pharmaceuticals, Inc. Inventory History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$24.9M
FY2025
5-year range
$1.5M / $24.9M
FY2021-FY2025
Trend
+11.1%
vs FY2024
Sector context
#75 of 105
Health Care
What the data says
At $25M, Mirum Pharmaceuticals, Inc.'s inventory ranks #75 of 105 in the Health Care sector. Inventory has increased for 5 consecutive years, from $0 in FY2020 to $25M in FY2025.
Based on SEC 10-K filings.
$25M in FY2025 with a 3-year CAGR of +64.8%.
Improved from $22M to $25M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +64.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#75 of 105 in Health CareTop 71% of 105This company $24.9M Sector average $885.3M
▼
-97.2% below sector average
Key checks
Key Insights
- Mirum Pharmaceuticals, Inc.'s inventory has grown for 4 consecutive years.
- 3-year CAGR of +64.8%, indicating consistent growth.
- In FY2025, inventory increased 11.1% year-over-year.
- Ranks #75 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $24.9M | +11.1% |
| FY2024 | $22.4M | +0.4% |
| FY2023 | $22.3M | +300.9% |
| FY2022 | $5.6M | +267.8% |
| FY2021 | $1.5M | - |
| FY2020 | $0 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026